Synta promotes ex-VC vet Schor to CEO and president
Lexington, Massachusetts-based Synta Pharmaceuticals Corp, a biopharmaceutical company focused on developing cancer medicines, has promoted Chen Schor from executive vice president and chief operating officer to president, CEO and director of the company. The change becomes effective May 7, 2015. Schor will be replacing Anne Whitaker who is leaving to pursue an opportunity at an unnamed pharmaceutical company. Schor is a former partner at at Yozma Venture Capital.
27 April 2015•3 mins read
